Vertical Augmentation With Osteon at Dental Implant Placement
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT01162629|
Recruitment Status : Unknown
Verified July 2010 by Research and Education in Dentistry.
Recruitment status was: Not yet recruiting
First Posted : July 14, 2010
Last Update Posted : July 15, 2010
|Condition or disease||Intervention/treatment|
|Tooth Injuries Tooth Abnormalities||Device: Osteon bone graft|
• To determine the success of dental implants in alveolar bone augmented in the vertical direction with Osteon.
Secondary Objectives • To determine the long term success of dental implants in this augmented bone.
• Radiographically assessed vertical height of alveolar ridge formation following Osteon augmentation.
|Study Type :||Observational|
|Estimated Enrollment :||100 participants|
|Official Title:||An Evaluation of Vertical Augmentation of Alveolar Bone With Osteon at Dental Implant Placement|
|Study Start Date :||September 2010|
|Estimated Primary Completion Date :||September 2015|
|Estimated Study Completion Date :||September 2015|
Patients requiring dental implants with deficient alveolar bone height
Device: Osteon bone graft
Osteon bone substitute placed to a height of 2 mm above the top of the dental implant
- The success of dental implants in alveolar bone augmented in the vertical direction with Osteon [ Time Frame: 3 years ]The implants will be deemed successful at each time point if the radiographic bone level remains at 2 mm above the level of the implant, i.e. at the same height as when placed. Given that we know precisely the dimensions of the abutments placed in the implant, this provides the necessary calibration in order to undertake this assessment. If the bone level is lost, the procedure will be deemed to have failed.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01162629
|Contact: Richard J Oliver, BDS PhDemail@example.com|
|Contact: Jason Buglass, BDS||00441743 firstname.lastname@example.org|
|Oracle Dental Clinics|
|Shrewsbury, Shropshire, United Kingdom, SY1 3GW|
|Principal Investigator:||Richard J Oliver, BDS PhD||Research and Education in Dentistry|